Vaccines

02 Apr 2016 Pandemic influenza vaccine receives positive CHMP opinion
02 Apr 2016 PJSC Pharmsynthez Completes Follow Up and Data Analysis From a Phase 2 Study of Novel Therapeutic Vaccine Xemys(TM) for Multiple Sclerosis
01 Apr 2016 Medigene announces Start of Phase II trial with DC vaccines and upcoming milestone payment
31 Mar 2016 GeoVax Extends Research Collaborations on Zika Vaccine
31 Mar 2016 Genital Herpes Immunotherapy GEN-003 Shows Sustained Reduction of Viral Shedding Rate, Durable Impact on Clinical Disease 12 Months Post-Dosing
31 Mar 2016 Inovio Ebola Vaccine Generates Robust Immune Responses in Humans
31 Mar 2016 Inovio Updates INO-3112 HPV Immunotherapy Development Plan
29 Mar 2016 BiondVax's Universal Flu Vaccine Phase 2b Clinical Trial Recruitment Complete
25 Mar 2016 New findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial
23 Mar 2016 Argos Therapeutics Announces Initiation of a Phase 2 Clinical Trial of AGS-003 for the Treatment of Non-small Cell Lung Cancer in Combination with Standard-of-Care Chemotherapy
19 Mar 2016 AXON Presented Its Tau Vaccine in Two Presentations at 14Th AAT Conference
17 Mar 2016 Vaxon Biotech completes enrollment of phase 2b lung cancer trial of first therapeutic vaccine based on optimized cryptic peptides
16 Mar 2016 Trials of a New Vaccine for Ebola to Take Place at RUSAL's Medical Centre in Guinea
16 Mar 2016 Publication in Retrovirology of the results of Biosantech's phase IIA clinical trial for the anti-HIV candidate vaccine
10 Mar 2016 Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer
10 Mar 2016 Medigene AG: Data and Safety Monitoring Board recommends advance of current DC vaccine clinical trial in AML into Phase II
07 Mar 2016 Data Safety and Monitoring Board Recommends Celldex's Phase 3 Study of RINTEGA® (rindopepimut) in Newly Diagnosed Glioblastoma be Discontinued as it is Unlikely to Meet Primary Overall Survival Endpoint in Patients with Minimal Residual Disease
07 Mar 2016 Stallergenes Greer Presents Findings from Four Allergy Immunotherapy Studies at the 2016 AAAAI Annual Meeting
07 Mar 2016 Aimmune Therapeutics Announces Phase 2 Follow-On Study of AR101 for the Treatment of Peanut Allergy Demonstrated Increased Desensitization and Improved Tolerability with Low-Dose Maintenance
03 Mar 2016 Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax(TM) Platform
03 Mar 2016 Vaxart Begins Preclinical Testing of an Oral Zika Virus Vaccine
23 Feb 2016 OncBioMune Continuing Phase 1 Trial, While Initiating Phase 2 Trial of ProscaVax for Prostate Cancer
23 Feb 2016 OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer
23 Feb 2016 OSE Pharma SA: First patients enrolled and dosed in the pivotal trial of Phase 3 of the immunotherapy Tedopi® for advanced non-small cell lung cancer
23 Feb 2016 OncoQR ML's Pancreatic Cancer Vaccine TYG100 Induces Clinically Relevant Immune Response Within Just 2 Weeks After Single Vaccination

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top